Total: 448 results found.
Page 6 of 23
CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist
Created on 2018-06-13 21:34:41
Cannabis Science (CBIS) Retains Cohen Grassroots Research Firm To Initiate Coverage Beginning With A 115-Page Analytical Report
Created on 2018-06-13 19:58:50
Former National Institute Of Health (NIH) Scientist Allen A. Herman, M.B., Ch.B., Ph.D., Joins The Cannabis Science Scientific Advisory Board (SAB)
Created on 2018-06-13 19:57:52
After Unveiling Its Products At Premiere Global Cannabis Event, Cannabis Science, Inc. Reports Strong Customer Interest
Created on 2018-06-13 19:56:39
Cannabis Science (CBIS) Names Investor Relations Veteran Of Leading Companies To Head Its Investor Relations Initiatives
Created on 2018-06-13 19:55:14
Cannabis Science (CBIS) Accepted To Present at ICAR 2015
Created on 2018-06-13 19:53:26
Cannabis Science Acquires Pet Care Manufacturer and Distributor Equi-Pharm & Enters the $60 Billion Pet Care Industry
Created on 2018-06-13 19:52:24
CBIS Expands Licensing Deal with Purple Haze Properties as it Launches 'Jimi's Cannabis Collection' Today at the Chicago 'Marijuana Business Conference and Expo'
Created on 2018-06-13 19:51:35
Cannabis Science Brings CS-TATI-1 to the FDA with Historic Collaborative Drug Development Deal With IGXBio and Its GenePro®, a DNA-Based Immunotherapeutic that Recently Received FDA Approval to Enter into Human Trials
Created on 2018-06-13 19:50:19
Cannabis Science, Inc. Initiates the Scientific Validation of the Biological Impact of Cannabinoids in Order to Better Define the Therapeutic Mechanism of Action Using Biochemical, Cell, and Genetic Approaches
Created on 2018-06-13 19:49:11
Cannabis Science, Inc. Initiates the Scientific Validation of the Biological Impact of Cannabinoids in Order to Better Define the Therapeutic Mechanism of Action Using Biochemical, Cell, and Genetic Approaches
Created on 2018-06-13 19:26:25
Mark Wainberg, Ph.D., Joins Cannabis Science's Scientific Advisory Board; Cannabis Science Presents Further Dimensions of CS-TATI-1 Discovery Platform at 8th IAS Conference on HIV Pathogenesis
Created on 2018-06-13 19:25:33
Cannabis Science Signs Gary Blick, MD and Proceeds With CS-TATI-1 for HIV and Kaposi Sarcoma Drug Development Program
Created on 2018-06-13 19:24:27
CBIS Appoints Hon. Ronald V. Dellums, Chairman of the New International Government Affairs Board, Served 27 Years as a Highly Respected Member of the US House of Representatives, and Served as Chairman of the US House Armed Services Committee
Created on 2018-06-13 19:17:51
Recent National Cancer Institute Cannabis Reports Encourages Cannabis Science to Ramp Up California Product Releases, Bring More Products to Market in State by State Regulated Markets and Expedite Its Formal FDA Cancer Initiatives Much Faster
Created on 2018-06-13 19:16:24
CBIS Appoints the Son of the Legendary Pan-Africanist, Marcus Garvey, Internationally Accredited Cardiovascular Surgeon Dr. Julius Garvey to Both Scientific & New International Governmental Affairs Boards
Created on 2018-06-13 19:15:25
Cannabis Science Positions Itself to Issue Dividend Payouts to Its Shareholders
Created on 2018-06-13 19:12:50
Cannabis Science, Inc. Takes Final Steps by Filing Dividend Paperwork With FINRA, While It Transitions Into the Equi-Pharm Acquisition and Its New Product Offerings
Created on 2018-06-13 19:11:18